Immatics NV IMTX Q1 2026 Earnings EPS Misses Estimates as Clinical Progress Drives Share Gains CATO Q4 2025 Earnings Loss of 055 per Share Amid Challenging Retail Environment Satellos Bioscience Q1 2026 Earnings Narrower Loss Reported Stock Slips on Lack of Revenue Progress ASO Q1 2026 Earnings EPS Misses Estimates but Stock Gains 29 Turn Therapeutics Inc TTRX Q1 2026 Earnings Narrow EPS Miss Overshadowed by Operational Progress QH Q4 2021 Earnings Massive EPS Miss Highlights Operational Challenges